EVALUATION OF COAGULATION AND HEMOSTASIS DISORDERS IN CIRRHOTIC PATIENTS TREATED AT THANH BA MEDICAL CENTER

Quốc Tuấn Lê, Thị Tuyết Nhung Trần

Main Article Content

Abstract

Objective: This study aims to evaluate the characteristics of coagulation and hemostasis disorders in cirrhotic patients treated at Thanh Ba Medical Center and analyze the correlation between the degree of liver fibrosis and coagulation indices. Methods: A cross-sectional descriptive study was conducted on 51 cirrhotic patients from January 2023 to December 2024. Patients underwent clinical evaluation, coagulation tests (PT, INR, aPTT, fibrinogen, D-dimer), and assessment of liver fibrosis using the Metavir scoring system. Results: Prothrombin time (PT) was prolonged (17.2 ± 3.5 seconds), INR increased (1.82 ± 0.45), aPTT extended (41.5 ± 8.3 seconds), fibrinogen decreased (1.8 ± 0.6 g/L), and D-dimer levels were elevated (1.2 ± 0.5 mg/L). Coagulation indices showed a strong correlation with the severity of liver fibrosis: the more advanced the fibrosis, the more severe the coagulation disorders. Conclusion: Cirrhotic patients are at high risk of both bleeding and thrombotic disorders. Monitoring coagulation parameters is essential for risk assessment and therapeutic management.

Article Details

References

Huỳnh Nghĩa (2015), “Bệnh lý đông máu huyết tương”, trong: Bài giảng Huyết học lâm sàng, Nhà xuất bản Y học, tr 125-168
2. Trần Thanh Tòng và cs (2024). Khảo sát đặc điểm rối loạn đông cầm máu trên bệnh nhân xơ gan tại Bệnh Viện Đa Khoa Đồng Tháp. Tạp chí Y Dược học Cần Thơ, Số 76, tr. 45-52.
3. Tripodi, A., Primignani, M., Chantarangkul, V., & Mannucci, P. M. (2011). The coagulopathy of chronic liver disease. The New England Journal of Medicine, 365(2), 147-156.
4. Lisman, T., Stravitz, R. T., & Violi, F. (2021). Hepatic coagulopathy in liver disease: Compensated and uncompensated hemostasis. Journal of Thrombosis and Haemostasis, 19(5), 1132-1143.
5. Violi, F., Ferro, D., Basili, S., & Muscari, S. (2016). Coagulopathy of chronic liver disease: A reappraisal. Blood Reviews, 30(2), 97-103.
6. Northup, P. G., Caldwell, S. H., & Bunchorntavakul, C. (2013). Hemostatic dysfunction in liver disease: Pathophysiology and critical assessment of current management. Hepatology, 58(4), 1527-1537.